Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Caliway Biopharmaceuticals Co Ltd (6919) Income Statement

Caliway Biopharmaceuticals Co Ltd Income Statement

Last quarter (Q2 2026), Caliway Biopharmaceuticals Co Ltd's total revenue was NT$3.57M, a decrease of 70.80% from the same quarter last year. In Q2, Caliway Biopharmaceuticals Co Ltd's net income was NT$-222.52M. See Caliway Biopharmaceuticals Co Ltd’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 37.98MNT$ 44.36MNT$ 38.88MNT$ 12.83MNT$ 12.32M
NT$ 26.48MNT$ 1.25MNT$ 27.44MNT$ -15.74MNT$ 9.22M
NT$ 732.57MNT$ 717.21MNT$ 540.27MNT$ 304.09MNT$ 239.65M
Depreciation and AmortizationNT$ 30.66MNT$ 29.50MNT$ 27.87MNT$ 25.34MNT$ 23.27M
NT$ -675.43MNT$ -686.45MNT$ -484.97MNT$ -294.49MNT$ -207.15M
NT$ -706.09MNT$ -715.96MNT$ -512.84MNT$ -319.82MNT$ -230.43M
NT$ 354.74MNT$ 128.10MNT$ 24.98MNT$ 33.49MNT$ 6.46M
NT$ -351.35MNT$ -587.85MNT$ -487.85MNT$ -286.33MNT$ -223.97M
NT$ -351.35MNT$ -587.85MNT$ -487.85MNT$ -286.33MNT$ -224.00M
Per Share Metrics
Basic EPSNT$ -0.23NT$ -0.41NT$ -0.39NT$ -0.24NT$ -0.24
Diluted EPSNT$ -0.23NT$ -0.41NT$ -0.39NT$ -0.24NT$ -0.24
Weighted Average Shares Outstanding1.54B1.43B1.24B1.17B919.74M
Weighted Average Shares Outstanding (Diluted)1.54B1.43B1.24B1.17B919.74M

Currency in TWD

Caliway Biopharmaceuticals Co Ltd Earnings and Revenue History

-800M-400M0400M-2400 %-1600 %-800 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin